The dilemma, causes and approaches to avoid recurrent hospital readmissions for patients with chronic heart failure

Heart failure is a progressive illness that carries significant morbidity and mortality. This highly prevalent illness leads to frequent, costly hospitalizations with approximately 50% of patients being readmitted within 6 months of initial hospitalization. While rehospitalization has been extensively studied in the past, little progress has been made in terms of reducing readmission rates of heart failure patients in the last decade despite increasing costs with impending resource limitations. We discuss disease-centered, physician-centered, and patient-centered factors that lead to rehospitalization as well as community/resource availability factors that contribute to rehospitalization of patients suffering from chronic heart failure. In addition, predictors of hospitalization and interventions that reduce hospitalization will be critically evaluated. With a complete understanding of heart failure rehospitalization, we hope the future holds more effective ways to prevent heart failure progression and thus rehospitalization, improved risk-stratification models to identify patients high-risk for rehospitalization, and sustained interventions that are customized according to the etiology of the clinical decline of heart failure patients that ultimately results in frequent rehospitalizations.

[1]  C. Yancy,et al.  Get with the guidelines steering committee and hospitals, sex and racial differences in the use of implantable cardioverter & defibrillators among patients hospitalized with heart failure , 2007 .

[2]  W. Maisel,et al.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. , 2003, The American journal of cardiology.

[3]  M. Cheitlin Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events , 2010 .

[4]  K. Ellison,et al.  Predictors of hospital readmission after discharge in patients with congestive heart failure. , 2005, Heart & lung : the journal of critical care.

[5]  C. O'connor,et al.  Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF , 2008, Circulation. Heart failure.

[6]  Y Wang,et al.  Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.

[7]  Harlan M Krumholz,et al.  Representation of the elderly, women, and minorities in heart failure clinical trials. , 2002, Archives of internal medicine.

[8]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[9]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[10]  M. Bristow,et al.  Economic impact of heart failure in the United States: time for a different approach. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  C. O'connor,et al.  Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. , 2008, Archives of internal medicine.

[12]  A. Takeshita,et al.  Medical and socioenvironmental predictors of hospital readmission in patients with congestive heart failure. , 2001, American heart journal.

[13]  T. Kasai,et al.  Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. , 2008, Chest.

[14]  S. Yusuf,et al.  Acute precipitants of congestive heart failure exacerbations. , 2001, Archives of internal medicine.

[15]  John L Sapp,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[16]  R. Eaton,et al.  Myxedema-associated Cardiogenic Shock Treated with Intravenous Triiodothyronine , 1992, Annals of Internal Medicine.

[17]  K M Hla,et al.  Population-based study of sleep-disordered breathing as a risk factor for hypertension. , 1997, Archives of internal medicine.

[18]  Sana M. Al-Khatib,et al.  Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. , 2010, Journal of the American College of Cardiology.

[19]  C M O'Connor,et al.  Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. , 2001, Archives of internal medicine.

[20]  B. Jonathan Comprehensive discharge planning and home follow-up of hospitalized elders: A randomized clinical trial , 1999 .

[21]  Anne L. Taylor,et al.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. , 2004, New England Journal of Medicine.

[22]  A. di Lenarda,et al.  [Prevention of heart failure]. , 2010, Giornale italiano di cardiologia.

[23]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[24]  M. Pfeffer,et al.  Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial , 2005, The Lancet.

[25]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[26]  John E A Blair,et al.  Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure. , 2008, JACC. Cardiovascular imaging.

[27]  A. Moss,et al.  Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II , 2006, Circulation.

[28]  S. Stewart,et al.  Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. , 1998, Archives of internal medicine.

[29]  M. Zile,et al.  Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. , 2008, Journal of the American College of Cardiology.

[30]  Jerome J. Schentag,et al.  Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure. , 1998, The American journal of cardiology.

[31]  C. Yancy,et al.  Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF). , 2009, American heart journal.

[32]  J. Rouleau,et al.  Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial , 2005, Canadian Medical Association Journal.

[33]  G. Fonarow,et al.  Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. , 2009, Journal of the American College of Cardiology.

[34]  S. Manzano-Fernández,et al.  Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. , 2009, The American journal of cardiology.

[35]  J. McMurray,et al.  Randomised controlled trial of specialist nurse intervention in heart failure , 2001, BMJ : British Medical Journal.

[36]  Y Wang,et al.  Predictors of readmission among elderly survivors of admission with heart failure. , 2000, American heart journal.

[37]  William T. Abraham,et al.  Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients: Initial Experience With a New Permanent Implantable Device , 2007, Circulation.

[38]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[39]  A. Takeshita,et al.  Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. , 2001, The American journal of cardiology.

[40]  F. Sheehan,et al.  Myocyte degeneration and cell death in hibernating human myocardium. , 1996, Journal of the American College of Cardiology.

[41]  Therapy Study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure , 1993, The Lancet.

[42]  William T. Abraham,et al.  Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure , 2010, Circulation.

[43]  C. O’loughlin,et al.  Causes and consequences of nonpersistence with heart failure medication. , 2009, The American journal of cardiology.

[44]  A. Gackowski,et al.  Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure , 2005 .

[45]  E. Rackow Rehospitalizations among patients in the Medicare fee-for-service program. , 2009, The New England journal of medicine.

[46]  A. Norberg,et al.  An Intervention Aimed at Reducing Uncertainty in Elderly Patients with Chronic Heart Failure , 2000, International Journal for Human Caring.

[47]  Christianna S. Williams,et al.  Prognostic importance of emotional support for elderly patients hospitalized with heart failure. , 1998, Circulation.

[48]  P. Nicod,et al.  The Thyroid and the Heart , 1993, Circulation.

[49]  J. Cahill,et al.  Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high‐risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin‐converting enzyme inhibitor dose at discharge , 2001, European journal of heart failure.

[50]  Gesica Investigators Randomised trial of telephone intervention in chronic heart failure: DIAL trial , 2005, BMJ : British Medical Journal.

[51]  H. Yagi,et al.  Decreased renal function as an independent predictor of re-hospitalization for congestive heart failure. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[52]  P A Poole-Wilson,et al.  Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. , 1999, Circulation.

[53]  D. DeMets,et al.  Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.

[54]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[55]  David D. Shin,et al.  Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. , 2007, Archives of internal medicine.

[56]  R. Califf,et al.  Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) , 2008, Circulation. Heart failure.

[57]  K. Witte,et al.  Chronic heart failure and multiple micronutrient supplementation: realistic hope or idealistic conjecture? , 2005, Heart failure monitor.

[58]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[59]  Gabriel Thabut,et al.  Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. , 2004, Journal of the American College of Cardiology.

[60]  K. Grumbach,et al.  Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity. , 1999, American heart journal.

[61]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[62]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[63]  Ibrahim N. Mansour,et al.  Six minute walk test predicts long-term all-cause mortality and heart failure rehospitalization in African-American patients hospitalized with acute decompensated heart failure. , 2009, Journal of cardiac failure.

[64]  L. Lenert,et al.  A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. , 2001, Journal of the American College of Cardiology.

[65]  Harlan M Krumholz,et al.  Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. , 2002, Journal of the American College of Cardiology.

[66]  L. Erhardt,et al.  Cost effective management programme for heart failure reduces hospitalisation , 1998, Heart.

[67]  M. Quiñones,et al.  Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. , 2005, Journal of the American College of Cardiology.

[68]  C. O'connor,et al.  Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. , 2003, The American journal of cardiology.

[69]  Harlan M. Krumholz,et al.  Recent National Trends in Readmission Rates After Heart Failure Hospitalization , 2010, Circulation. Heart failure.

[70]  M. Bristow,et al.  Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. , 1996, Circulation.

[71]  I. Alhaddad,et al.  A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients. , 2001, Journal of the American College of Cardiology.

[72]  R. Carney,et al.  A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. , 1995, The New England journal of medicine.

[73]  John G F Cleland,et al.  Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. , 2007, Journal of cardiac failure.

[74]  R. Cooper,et al.  Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. , 1988, Archives of internal medicine.

[75]  CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[76]  Effect of carvedilol on survival in severe chronic heart failure. , 2001 .

[77]  J. Conti,et al.  Current trends in heart failure readmission rates: analysis of medicare data , 2009, Clinical cardiology.

[78]  Sharon-Lise T. Normand,et al.  An Administrative Claims Measure Suitable for Profiling Hospital Performance on the Basis of 30-Day All-Cause Readmission Rates Among Patients With Heart Failure , 2008, Circulation. Cardiovascular quality and outcomes.

[79]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[80]  J. McMurray,et al.  Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. , 2004, Journal of the American College of Cardiology.

[81]  N. Sharpe,et al.  Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.

[82]  Haya R Rubin,et al.  Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. , 2004, JAMA.

[83]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[84]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[85]  Gerasimos Filippatos,et al.  Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. , 2007, Journal of cardiac failure.

[86]  I. Kubota,et al.  Combination of conventional biomarkers for risk stratification in chronic heart failure. , 2009, Journal of cardiology.

[87]  S. Yusuf,et al.  Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .

[88]  G. Fonarow,et al.  Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. , 2009, The American journal of medicine.

[89]  Simon Stewart,et al.  Home-Based Intervention in Congestive Heart Failure: Long-Term Implications on Readmission and Survival , 2002, Circulation.

[90]  H. Yagi,et al.  Inhibition of the renin-angiotensin system prevents re-hospitalization of heart failure patients with preserved ejection fraction. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[91]  L. Carbone,et al.  Macro- and micronutrients in African-Americans with heart failure , 2006, Heart Failure Reviews.

[92]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[93]  D. Battleman,et al.  Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. , 2002, Archives of internal medicine.

[94]  Paula Finn,et al.  American Heart Association--scientific sessions 2005. 13-16 November 2005, Dallas, TX, USA. , 2006, IDrugs : the investigational drugs journal.

[95]  L. Stevenson,et al.  CardioMEMS Heart Sensor Allows Monitoring of Pressures to Improve Outcomes in NYHA Class III Heart Failure Patients (CHAMPION) Trial: Impact of Hemodynamic Guided Care on Patients With Preserved Ejection Fraction , 2010 .

[96]  B. Kozłowski [Commentary to the article: Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-38]. , 2009, Kardiologia polska.

[97]  G. Schulz,et al.  Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. , 1998, Journal of the American College of Cardiology.

[98]  A. Casta,et al.  Cardiac complications in juvenile hyperthyroidism. , 1984, American journal of diseases of children.

[99]  W. Kannel,et al.  Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.

[100]  P. Armstrong,et al.  Renal Insufficiency and Heart Failure: Prognostic and Therapeutic Implications From a Prospective Cohort Study , 2004, Circulation.

[101]  Harlan M Krumholz,et al.  Renal impairment and outcomes in heart failure: systematic review and meta-analysis. , 2006, Journal of the American College of Cardiology.

[102]  L Goldman,et al.  Correlates of early hospital readmission or death in patients with congestive heart failure. , 1997, The American journal of cardiology.

[103]  W. Tang,et al.  Aldosterone-Receptor Antagonists in Heart Failure: Insights After EMPHASIS-HF , 2011, Current heart failure reports.

[104]  J. Keaney,et al.  Are ACE inhibitors a "magic bullet" against oxidative stress? , 2001, Circulation.

[105]  R. Cody,et al.  Discharge Education Improves Clinical Outcomes in Patients With Chronic Heart Failure , 2005, Circulation.

[106]  J. Killian,et al.  Prognostic Value of Biomarkers in Heart Failure: Application of Novel Methods in the Community , 2009, Circulation. Heart failure.